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Background. General anesthesia is an essential element of experimental medical procedures. Ketamine and isoﬂurane are agents
commonly used to induce and maintain anesthesia in animals. The cardiovascular eﬀects of these anesthetic agents are diverse,
and the response of global myocardial function is unknown. Methods. In a series of 15 swine, echocardiography measurements of
left ventricular ejection fraction (LVEF) were obtained before the animals received anesthesia (baseline), after an intramuscular
injection of ketamine (postketamine) and after inhaled isoﬂurane (postisoﬂurane). Results. The mean LVEF of an unanesthetized
swinewas 47 ± 3%. There was a signiﬁcantdecrease inthe meanLVEF after administrationofketamineto 41 + 6.5% (P = 0.003).
The addition of inhaled isoﬂurane did not result in further decrease in mean LVEF (mean LVEF 38 ± 7.2%, P = 0.22). Eight of
the swine had an increase in their LVEF with sympathetic stimulation.Conclusions. In our experimental model the administration
of ketamine was associated with decreased LV function. The decrease may be largely secondary to a blunting of sympathetic tone.
The addition of isoﬂurane to ketamine did not signiﬁcantly change LV function. A signiﬁcant number of animals had returned to
preanesthesia LV function with sympathetic stimulation.
1.Introduction
Anesthesia is frequently required during the medical man-
agement of animals for both therapeutic procedures and
experimental models. The response of the cardiovascular
system to anesthetic agents can be highly variable, based
on agent selection, dosing, and the experimental model [1–
3]. Commonly used induction and maintenance anesthesia
protocols involve agents that are known to eﬀect the
sympathetic and parasympathetic nervous systems, vascular
tone, and contractile properties of the myocardium [4–6].
Ketamine, a derivative of phencyclidine and cyclohexamine,
is a NMDA antagonist that is frequently used to induce
anesthesia in swine experimental models. It acts on the
thalamocortical, reticular activating, and limbic systems [7].
After induction, anesthesia maintenance is often achieved
with the inhaled agent isoﬂurane, an halogenated ether that
is one of the least cardiotoxic agents available [3]. Limited
models exist to describe the complex cardiovascular eﬀects
of ketamine which include increased heart rate, cardiac
output, and vascular resistance. A model using isolated
chick embryo hearts suggests that this agent decreases
myocardial contractile amplitude [8]. So too, there is limited
information onthe cardiovascular eﬀectsofisoﬂurane which
has been suggested to decrease aortic pressures, cardiac
output, stroke volume, and contractility [3, 9, 10]. Descrip-
tions of the eﬀects of these agents on global myocardial
function are limited to isolated muscle preparations or
diﬀerent animal models [11, 12]. The speciﬁc eﬀects of
these agents on global systolic myocardial function in vivo
have not been fully evaluated and are critical to under-
standing the physiologicresponses to generalanesthesia. The
hypothesis of this work is that global myocardial systolic
function is aﬀected by both ketamine and isoﬂurane. In this
analysis we use standard echocardiography techniques to
evaluate the short-term changes in left ventricular ejection
fraction after exposure to ketamine and isoﬂurane in a
swine model.2 ISRN Cardiology
2.Methods
Young male domesticated swine, four to eight weeks old and
weighing 8 to 12kg, were used in this study. The research
protocol was approved by the Animal Research Committee
of Tufts Medical Center and conducted in accordance
with the regulations of the Association for Assessment and
Accreditation of Laboratory Animal Care.
The anesthesia protocol has been previously published
[13]. Swine were sedated with intramuscular ketamine at a
concentration of 12 milligrams per kilogram of body weight.
Animals were then intubated and anesthetized with inhaled
isoﬂurane which was maintained at 1.0 to 2.0 percent mixed
withoxygenandnitrousoxide.Eachanimalwasplacedprone
in a sling to approximate physiologic cardiac anatomy and
hemodynamics. The anesthesia protocol and experimental
design described here are part of a larger research program
evaluatingsuddendeathduetolow-energychest-wall impact
(commotio cordis) [13].
Echocardiography wasperformed atthestart ofthestudy
priortoketamineadministration, whiletheanimalwasbeing
held on the stretcher (baseline). Views included parasternal
short and long axis, and apical 2 and 4 chamber. Echocardio-
graphy was repeated 5 minutes after ketamine administra-
tion, and then again 5 minutes after isoﬂurane administra-
tion.After inductionofventricularﬁbrillation by ball impact
and deﬁbrillation, echocardiocardiography was repeated
[13–15]. Heart rates were obtained at each echocardiograph-
ic study for each subject.
3.Data Analysis
Echocardiograms were reviewed by a single board certiﬁed
echocardiographer (N.P.) who was blinded to swine speciﬁc
dataandtothestageoftheexperimentalprotocol.Theglobal
left ventricular ejection fraction (LVEF) was quantitatively
assessed as well as the presence or absence of wall motion
abnormalities.
Results are presented as mean ± standard deviation
unless otherwise speciﬁed. Data were analyzed using Two-
Sample Independent t tests. Statistical signiﬁcance was set at
a probability value of P<0.05 with a two sided conﬁdence
interval and assuming equal variance. The statistical analyses
were run using SPSS Version 17.0. SPSSInc., IBM Company,
233S. Wacker Drive, Chicago, Illinois 60606.
4.Results
Fifteen swine with a mean weight of 9.9 ± 1.4kg were used
for this analysis. Prior to anesthesia the mean heart rate of
the swine was 144 ± 17bpm and the mean LVEF was 47
± 3.2%. No wall motion abnormalities were identiﬁed at
baseline (Tables 1 and 2).
After ketamine the mean heart rate was unchanged at
147 ± 14bpm (P = ns). As compared to baseline, there
was a signiﬁcant decrease in the mean LVEF to 41 ± 6.5%,
(P = 0.003).A decrease in LVEF was observed in 12 ofthe 15
(80%) subjects, with 3 subjects showing no change in global
left ventricular function (Figures 1 and 2). In these animals,
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Figure 1: Mean left ventricular ejection fraction and relationship
to anesthetic. Baseline (blue), postketamine sedation (red), and
postisoﬂurane (green) left ventricular ejection fraction data are
shown. Results are presented as mean LVEF ± standard deviation.
Signiﬁcantchange from baseline EF is identiﬁed by ∗(P<0.05).
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Figure 2: Left ventricular ejection fraction by individual subject at
baseline (blue diamonds), postketamine (red squares), and posti-
soﬂurane (green triangles).
theLVEFdecreasedbyameanvalueof12.8±13.0%fromthe
baseline. There were no wall motion abnormalities evident
after ketamine administration.
After administration of isoﬂurane, the mean heart rate
dropped signiﬁcantly to 132 ± 22bpm (P = 0.03). Ten
of the 15 (67%) subjects demonstrated an overall further
decrease in LVEF with the addition of isoﬂurane, with the
LVEF decreasing by a mean value of 19.6 ± 15.1% from the
baseline. There was a slight overall further decrease in mean
LVEF, but this value was not signiﬁcantly lower than after
ketamine administration (38 ± 7.2%, P = 0.22) (Tables 1
and2).Therewasasinglewallmotionabnormalityidentiﬁed
in the postisoﬂurane study for subject no. 2. This caseISRN Cardiology 3
Table 1:AnimalData.Ejectionfraction(EF)measurementsweremadeusingstandardechocardiographytechniques. Pulseratewasrecorded
using standard ECG techniques and is presented as beats per minute. Pre-ket represents the starting values, Post-ket represents the values
after ketamine was administered. Post-iso represents the values after isoﬂurane was administered. Postdeﬁbrillation represents the values
after induction of ventricular ﬁbrillation and successful deﬁbrillation. ∗Animals did not recover from ventricular ﬁbrillation.
Animal no. Pre-ket
EF
Pre-ket
pulse
Post-ket
EF
Post-ket
pulse
Post-iso
EF
Post-iso
pulse
Postdeﬁbrillation
EF
Postdeﬁbrillation
pulse
1 0.50 144 0.35 162 0.30 108 0.35 106
2 0.45 156 0.45 136 0.35 97 0.28 96
3 0.45 152 0.30 148 0.28 156 0.25 130
4 0.45 156 0.45 152 0.45 161 0.45 138
5 0.43 144 0.40 152 0.28 138 0.15 120
6 0.48 164 0.45 160 0.30 111 0.30 125
7 0.45 168 0.40 132 0.30 122 0.30 95
8 0.45 152 0.40 153 0.48 153 0.48
9 0.45 100 0.40 120 0.35 132 0.45 119
10 0.50 128 0.45 144 0.40 136 0.48 131
11 0.50 132 0.45 152 0.45 121 ∗ 74
12 0.55 132 0.50 136 0.45 112 0.55 138
13 0.45 136 0.25 176 0.40 163 ∗ 82
14 0.45 156 0.40 144 0.40 157 0.50 71
15 0.45 136 0.45 136 0.45 112 0.55 61
Table 2: Hemodynamics. Values are mean ± SEM. LVEF is the
left ventricular ejection fraction from blinding echocardiography.
∗Indicates P< 0.05 compared with baseline.
Parameters Baseline Postketamine Postisoﬂurane
N 15 15 15
Heart rate, bpm 143.7 ± 17.2 146.9 ± 13.8 131.9 ± 22.0
LVEF 0.47 ± 0.01 0.41 ± 0.02∗ 0.38 ± 0.02∗
demonstrated severe hypokinesis of the distal apical septum
(Figures 1 and 2).
After initiation of ventricular ﬁbrillation by baseball
strikesto thechest wall and deﬁbrillation,7 ofthe15 animals
had a return to preanesthesia LVEF (Table 1).
5.Discussion
Ketamine and isoﬂurane are frequently used in experimental
animal models to induceand maintain anesthesia. This is the
ﬁrst study to evaluate the short-term eﬀects of these agents
on global myocardial function in a live, whole animal model.
Ketamine has signiﬁcant and varied eﬀects on cardiovas-
cular physiology. The contractility and global LVEF changes
documented in this swine model are consistent with a report
by Schulte-Sasse et al. that showed short-term elevation
of ﬁlling pressures with ketamine use in human subjects
undergoingcoronary artery bypassoperations[16].The data
presented here suggest that this rise in ﬁlling pressure is
largely related to a decrease in global left ventricular systolic
function. Numerous reports in various animal models have
worked to deﬁne these changes. In one dog model, for
example, there appeared to be an overall increase in stress-
related hormones [17]. E x p e r i m e n t so nr a t sa n dg u i n e ap i g s
have noted that ketamine tends to not only increase blood
pressure and heart rate but also decrease left ventricular
diastolic pressure. The latter changes have been linked to
cation movement, speciﬁcally magnesium, and associated
kinase pathways [18].
Recentmolecularwork mightoﬀerfurther insight forthe
cardiodepressive eﬀects of ketamine. Speciﬁcally, Kawano et
a l .h a v ed e m o n s t r a t e di na ni nv i t r om o d e lt h a tk e t a m i n e
induces inhibition of sarcolemmal K + ATP sensitive potas-
siumchannels [19].Blockadeofthesechannels haslongbeen
associated with decreased contractility [20]. Additionally,
recent descriptions in a cat model demonstrate increased
histamine release, which has also been linked to global car-
diovascular depression [21].
There are limited data on the cardiovascular eﬀects of
isoﬂurane in animal models and even fewer reports of the
cardiac response in humans. Early reports on human sub-
jects suggest that there are minimal short-term myocardial
depressive eﬀects with isoﬂurane and that the pulmonary
capillary wedge pressure does not signiﬁcantly change [22,
23]. In contrast to these human reports, animal models have
shown more substantial myocardial depressive eﬀects. An
echocardiographic study of rats anesthetized with various
anesthetic agents showed that isoﬂurane resulted in a
statistically signiﬁcant decrease in left ventricular ejection
fraction compared with conscious controls [24]. There is
a recent swine model description of isoﬂurane-induced
changes in myocardial function; however, echocardiographic4 ISRN Cardiology
parameters are not used. Instead, decreases in systolic
function were measured with more invasive ultrasound
techniques [25]. The results of our work are consistent with
an overall minimal short-term myocardial depressive eﬀect
seen in humans with a trend towards the depressive eﬀects
seen in previous animal work.
The molecular basis of isoﬂurane induced myocardial
depression has long been postulated to relate to the regula-
tion of calcium and its relationship to important contractile
elements.Isoﬂuranedecreasestheamountofcalciumpresent
in the sarcoplasmic reticulum [26]. Additionally, there is
evidence that this anesthetic directly inhibits the sarcolem-
mal calcium channels themselves [27]. These changes result
in decreased concentrations of calcium being released and
available to elements of contraction and might contribute to
a decrease in global systolic function.
The overall short-term myocardial depressive eﬀects of
ketamine and the trend towards depressive eﬀects of isoﬂu-
rane on the swine myocardium have important experi-
mental implications. These short-term changes should be
considered when interpreting experimental hemodynamic
changes. Additionally, while there have not been systematic
evaluations of these agents and their short-term eﬀects on
human systolic function, it is reasonable to hypothesize
that the human heart undergoes similar short-term changes
when exposed to these agents. Lastly, arrhythmic, ischemic,
and heart failure disease states in human research studies
are all independently associated with decreasing left ven-
tricular ejection fraction [28–30]. It is reasonable to inter-
pret results from experimental models such as those within
the framework of a somewhat reduced ejection fraction,
not in the context of the starting, preanesthetic ejection
fraction.
There are several limitations to this work. It should be
noted that the baseline values in this study were obtained
while the animals were excited as they were without anes-
thesia. As a result, these values may represent a baseline
sympathetic-induced increase in ejection fraction [31].
Although it is possible that the change in ejection fraction
after ketamine injection is due in part to a decrease from a
baseline sympathetically elevated ejection fraction, the lack
of signiﬁcant change in heart rate suggests that the swine
were unlikely to be signiﬁcantly sympathetically activated.
Importantly, the results here represent only short-term
changes associated with these agents. The eﬀects seen here
do not allow comment on the long-term eﬀects of ketamine
and isoﬂurane on global systolic function. An additional
limitation relates to the concentration of isoﬂurane used. In
a dog experimental model there were signiﬁcant decreases in
contractility indices seen at isoﬂurane concentrations over
2%. These eﬀects were not seen at concentrations of 1.25%
[3]. The concentrations used in our experimental model
were maintained in the 1% to 2% range. This might account
fortheobservationsofvariableresponse,inconsistentchange
in ejection fraction, and a lack of statistically signiﬁcant
change with the addition of isoﬂurane. Speciﬁcally, the
concentrationsusedheremighthavebeenoccasionallybelow
an unknown threshold value that is needed to induce
depression of myocardial function.
6.Conclusion
Ketamine use was associated with a signiﬁcant short-term
decrease in LV function in this experimental swine model.
The decrease may be largely dueto a blunting of sympathetic
tone. The addition of isoﬂurane to ketamine did not sig-
niﬁcantly change global LV function. A signiﬁcant number
of animals had returned to preanesthesia LV function with
subsequent sympathetic stimulation.
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